EV

Elikon Venture

Asia, Shanghai, China, Shanghai

Description

Elikon Venture is a venture capital firm.

Investor Profile

Elikon Venture has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (33%)
  • Series A (33%)
  • Series C (33%)

Country Focus

  • United States (67%)
  • China (33%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Elikon Venture frequently co-invest with?

INCE Capital
Asia, Shandong, China, Pudong
Co-Investments: 1
Med-Fine Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
OC
North America, New York, United States, New York
Co-Investments: 1
TF Capital
Asia, Shandong, China, Pudong
Co-Investments: 2
LongRiver Investments
Asia, Shanghai, China, Xuhui
Co-Investments: 1
3SBio Inc.
Asia, Liaoning, China, Shenyang
Co-Investments: 1
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Firstred Capital
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Elikon Venture?

Angitia Biopharmaceuticals

Guangzhou, Guangdong, China

Angitia Biopharmaceuticals is a global biotechnology company focusing on the discovery and development of innovative therapeutics.

BiopharmaBiotechnologyHealth CareMedical
Series CDec 11, 2024
Amount Raised: $120,000,000
Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics
Series BMar 9, 2023
Amount Raised: $50,000,000
Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics
Series ANov 24, 2021
Amount Raised: $40,000,000